![Jason Gross](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Gross
Directeur Technique/Scientifique/R&D chez
HLS THERAPEUTICS INC.
Fortune : 134 190 $ au 31/08/2026
Profil
Jason A. Gross is currently Vice President-Scientific Affairs at HLS Therapeutics, Inc., a position held since 2014.
Former roles include Vice President-Scientific & Medical Affairs at Cipher Pharmaceuticals, Inc. from 2012 to 2013, Vice President at Lumira Capital Investment Management, Inc., VP-Scientific & Medical Affairs at IVAX Pharmaceuticals, Inc., VP-Regulatory Affairs & Quality Assurance at Drugabuse Sciences, Inc., and Vice President-Scientific Affairs at HLS Therapeutics, Inc. Education includes a doctorate from the University of Arizona.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
HLS THERAPEUTICS, INC. 0,16 % | 26/06/2026 | 49 700 ( 0,16 % ) | 134 190 $ | 31/08/2026 |
Postes actifs de Jason Gross
| Sociétés | Poste | Début |
|---|---|---|
| HLS THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 01/06/2014 |
Anciens postes connus de Jason Gross
| Sociétés | Poste | Fin |
|---|---|---|
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Private Equity Investor | 31/03/2006 |
HLS Therapeutics, Inc. /Old/
 HLS Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides specialty pharmaceutical products | Corporate Officer/Principal | - |
IVAX Pharmaceuticals, Inc.
 IVAX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Directeur Technique/Scientifique/R&D | - |
Drugabuse Sciences, Inc. | Conseiller Juridique Général | - |
| CIPHER PHARMACEUTICALS INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Jason Gross
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
25
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Cipher Pharmaceuticals, Inc.
 Cipher Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Provides laboratory testing and medical imaging services | Health Technology |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Finance |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IVAX Pharmaceuticals, Inc.
IVAX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Drugabuse Sciences, Inc. | |
HLS Therapeutics, Inc. /Old/
HLS Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides specialty pharmaceutical products | Health Technology |
HLS Therapeutics, Inc.
 HLS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
